These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34970213)

  • 1. Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic Stroke.
    Gao L; Bivard A; Parsons M; Spratt NJ; Levi C; Butcher K; Kleinig T; Yan B; Dong Q; Cheng X; Lou M; Yin C; Chen C; Wang P; Lin L; Choi P; Miteff F; Moodie M
    Front Neurol; 2021; 12():780894. PubMed ID: 34970213
    [No Abstract]   [Full Text] [Related]  

  • 2. Endovascular thrombectomy in patients with large core ischemic stroke: a cost-effectiveness analysis from the SELECT study.
    Sarraj A; Pizzo E; Lobotesis K; Grotta JC; Hassan AE; Abraham MG; Blackburn S; Day AL; Dannenbaum MJ; Hicks W; Vora NA; Budzik RF; Sharrief AZ; Martin-Schild S; Sitton CW; Pujara DK; Lansberg MG; Gupta R; Albers GW; Kunz WG;
    J Neurointerv Surg; 2021 Oct; 13(10):875-882. PubMed ID: 33188155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke.
    Peultier AC; Pandya A; Sharma R; Severens JL; Redekop WK
    JAMA Netw Open; 2020 Aug; 3(8):e2012476. PubMed ID: 32840620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center.
    Nannoni S; Strambo D; Sirimarco G; Amiguet M; Vanacker P; Eskandari A; Saliou G; Wintermark M; Dunet V; Michel P
    J Neurointerv Surg; 2020 Sep; 12(9):842-847. PubMed ID: 31772044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging criteria across pivotal randomized controlled trials for late window thrombectomy patient selection.
    Menon BK; Ospel JM; McTaggart RA; Nogueira RG; Demchuk AM; Poppe A; Rempel JL; Zerna C; Joshi M; Almekhlafi MA; Field TS; Dowlatshahi D; van Adel BA; Sauvageau E; Tarpley J; Moreira T; Bang OY; Heck D; Psychogios MN; Tymianski M; Hill MD; Goyal M;
    J Neurointerv Surg; 2020 Nov; ():. PubMed ID: 33239306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for Endovascular Trial Enrollment in the 6- to 24-Hour Time Window: Analysis of a Single Comprehensive Stroke Center.
    Jadhav AP; Desai SM; Kenmuir CL; Rocha M; Starr MT; Molyneaux BJ; Gross BA; Jankowitz BT; Jovin TG
    Stroke; 2018 Apr; 49(4):1015-1017. PubMed ID: 29581344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular Thrombectomy for Acute Ischemic Stroke.
    Hasan TF; Todnem N; Gopal N; Miller DA; Sandhu SS; Huang JF; Tawk RG
    Curr Cardiol Rep; 2019 Aug; 21(10):112. PubMed ID: 31471811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombectomy in Acute Ischemic Stroke in the Extended Time Window: Real-Life Experience in a High-Volume Center.
    Virtanen P; Tomppo L; Martinez-Majander N; Kokkonen T; Sillanpää M; Lappalainen K; Strbian D
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106603. PubMed ID: 35749938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEFUSE 3 Non-DAWN Patients.
    Leslie-Mazwi TM; Hamilton S; Mlynash M; Patel AB; Schwamm LH; Lansberg MG; Marks M; Hirsch JA; Albers GW
    Stroke; 2019 Mar; 50(3):618-625. PubMed ID: 30727856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential responders.
    Ducroux C; Khoury N; Lecler A; Blanc R; Chetrit A; Redjem H; Ciccio G; Smajda S; Escalard S; Desilles JP; Mazighi M; Ben Maacha M; Piotin M; Fahed R
    Eur J Neurol; 2018 Aug; 25(8):1093-1099. PubMed ID: 29667266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population health impact of extended window thrombectomy in acute ischemic stroke.
    Zhou MH; Kansagra AP
    Interv Neuroradiol; 2021 Aug; 27(4):516-522. PubMed ID: 33153379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR CLEAN-LATE, a multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands for late arrivals: study protocol for a randomized controlled trial.
    Pirson FAVA; Hinsenveld WH; Goldhoorn RB; Staals J; de Ridder IR; van Zwam WH; van Walderveen MAA; Lycklama À Nijeholt GJ; Uyttenboogaart M; Schonewille WJ; van der Lugt A; Dippel DWJ; Roos YBWEM; Majoie CBLM; van Oostenbrugge RJ;
    Trials; 2021 Feb; 22(1):160. PubMed ID: 33627168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the Long-Term Health Outcome and Costs of Thrombectomy in Treating Stroke Patients with Large Ischaemic Core: Comparison between Clinical Trials and Real-World Data.
    Gao L; Moodie M; Levi C; Lin L; Cheng X; Kleinig T; Butcher K; Yan B; Bivard A; Parsons M
    Cerebrovasc Dis; 2023; 52(2):137-144. PubMed ID: 36516799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort Study.
    Siegler JE; Messé SR; Sucharew H; Kasner SE; Mehta T; Arora N; Starosciak AK; De Los Rios La Rosa F; Barnhill NR; Mistry AM; Patel K; Assad S; Tarboosh A; Dakay K; Salwi S; Wagner J; Bennett A; Jagadeesan BD; Streib C; Weber SA; Chitale R; Volpi JJ; Mayer SA; Yaghi S; Jayaraman M; Khatri P; Mistry EA
    Neurosurgery; 2020 Feb; 86(2):E156-E163. PubMed ID: 31758197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between collateral status and DEFUSE 3 or DAWN criteria in patient selection for endovascular thrombectomy within 6-24 hours after stroke: a protocol for meta-analysis.
    Shen Y; Li M; Chen Y; Liu S; Liu J; Yang D
    BMJ Open; 2022 Oct; 12(10):e059557. PubMed ID: 36288829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Endovascular Therapy for Stroke Cost-Effective Globally? A Systematic Review of the Literature.
    Waqas M; Gong AD; Levy BR; Dossani RH; Vakharia K; Cappuzzo JM; Becker A; Sonig A; Tutino VM; Almayman F; Davies JM; Snyder KV; Siddiqui AH; Levy EI
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105557. PubMed ID: 33556672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of endovascular thrombectomy in patients with low Alberta Stroke Program Early CT Scores (< 6) at presentation.
    Wu X; Payabvash S; Matouk CC; Lev MH; Wintermark M; Sanelli P; Gandhi D; Malhotra A
    J Neurosurg; 2021 Dec; 135(6):1645-1655. PubMed ID: 33962378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Cost-Effectiveness of Severity-Based Triaging for Large Vessel Occlusion Stroke.
    Gao L; Moodie M; Yassi N; Davis SM; Bladin CF; Smith K; Bernard S; Stephenson M; Churilov L; Campbell BCV; Zhao H
    Front Neurol; 2022; 13():871999. PubMed ID: 35645977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of death after endovascular thrombectomy in the extended window: a secondary analysis of DEFUSE 3 ".
    Taussky P; Agnoletto G; Grandhi R; Alexander MD; Wong KH; Albers GW; de Havenon A
    J Neurointerv Surg; 2021 Sep; 13(9):805-808. PubMed ID: 33077580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.